Raven Jackson
Raven Jackson, PharmD
Clinical Assistant Professor
Division of Clinical and Administrative Sciences
Dr. Jackson teaches in several courses within the PharmD curriculum including Neurology Therapeutics, Interprofessional Education, Medication Therapy Management, Self Care Therapeutics, Point of Care Testing, as well as a lecture on the Pharmacogenomics of Diabetes. Dr. Jackson also teaches an Infectious Disease Point of Care Testing Lab. As a component of her clinical position, Dr. Jackson provides Diabetes Medication Management at the Family Doctor’s Clinic at West Jefferson Medical Center where she serves as a preceptor for both Advanced Pharmacy Practice Experience and Introductory Pharmacy Practice Experience.
After graduating from Xavier’s College of Pharmacy in 2014, Dr. Jackson went on to complete her Post Graduate Year 1 (PGY-1) training at Purdue University, in partnership with Walgreens where she obtained skills in Medication Therapy Management, Point of Care Testing, Diabetes Care, Precepting, and Pharmacy Management. During this time, she also successfully completed the Indiana Pharmacy Teaching Certificate Program (IPTeC). After completion of her residency, Dr. Jackson obtained a position as Pharmacy Manager of a Walgreens location in Texas where she remained for one year prior to accepting her current role at Xavier University.
Education:
PharmD: 91勛圖厙 College of Pharmacy, 2014
PGY1 Community Based Residency – Purdue University/Walgreens Company, 2015
Clinical Specialties: (as applies)
Diabetes Management
Medication Therapy Management
Point of Care Testing
Teaching Areas: (as applies)
Neurology Therapeutics
Interprofessional Education
Medication Therapy Management
Self Care Therapeutics
Point of Care Testing
Advanced Pharmacy Practice Experience (Ambulatory Care)
Introductory Pharmacy Practice Experience (Ambulatory Care)
Pharmacogenomics of Diabetes
Research Interests: (as applies)
Dr. Jackson’s primary research interests include evaluating effective pedagogical practices for experiential learning as well as assessing changes in the climate of community pharmacy.
Select Publications: (as applies)
Jackson, R., Hopgood, C., Nguyen, V. How Pharmacists Will Practice in 2015: A 2017 Response. Pharmacy Times. September 17, 2017.
Thomas Wiese, PhD
Professor of Biochemistry
Division of Basic Pharmaceutical Sciences
Dr. Wiese teaches molecular biology, biochemistry, medicinal chemistry and cancer biology in the PharmD curriculum and also maintains an active research laboratory involving PharmD students. Dr. Wiese is the Xavier Associate Director of the Louisiana Cancer Research Consortium (LCRC) that includes Tulane University, LSU Health Science Center and Ochsner Clinic. He also serves in the Xavier RCMI (Research Center in Minority Institutions) cancer research program as Associate Director for Professional Development and co-director of the Cell and Molecular Biology Core Facility.
Dr. Wiese received a B.S. in Biology (minor in Chemistry) from the University of Michigan-Flint in 1984 and then worked as an analytical chemist in an industrial chemical company before entering graduate school at Wayne State University School of Medicine in the Biochemistry Department. As a graduate student, he developed a research project in the laboratory of Dr. Samuel Brooks that characterized the steroid ligand specificity of the estrogen receptor and completed his Ph.D. in 1995. After teaching one year in the Chemistry Department of The University of Detroit-Mercy, Dr. Wiese accepted a post-doctoral research fellowship in the toxicology program at The University of North Carolina at Chapel Hill where he trained in the laboratories of Drs. William Kelce and L. Earl Gray at the US EPA NHEERL and developed projects addressing the molecular mechanisms of endocrine disrupting environmental chemicals. In 1998, Dr Wiese accepted a State of Louisiana joint faculty position in both the Tulane School of Public Health and Tropical Medicine and the 91勛圖厙 College of Pharmacy where he he developed a research program addressing the cellular and molecular aspects of endocrine disruption in cancer promotion and progression. In 2003, Dr. Wiese consolidated and focused his career by moving fulltime to the 91勛圖厙 College of Pharmacy where he currently serves as a tenured faculty.
Education:
Post-Doctoral Fellowship, Toxicology, University of North Carolina at Chapel Hill, 1995-98
Ph.D., Biochemistry, Wayne State University School of Medicine, 1995
B.S., Biology, University of Michigan – Flint, 1984
Teaching Areas:
PHSC 3810, Pharmacy Biochemistry and Molecular Biology
PHSC 3910, Medicinal Chemistry-Pharmacology I
PHSC 4910, Medicinal Chemistry-Pharmacology II
PHSC 5910, Medicinal Chemistry-Pharmacology IV
PHCY 4001, BIOL 4000, Cancer: Causes, Treatments and Disparities
Research Interests:
The primary theme of research in the Wiese lab is study of the molecular mechanisms involved in nuclear receptor mediated endocrine disruption. Projects underway include characterizations of gene, receptor and tissue specific effects of hormone active environmental chemicals, natural products, pharmaceuticals, personal care products and dietary supplements. The goal of these studies is to define the endocrine disruption of these substances as primary molecular level events that might contribute to hormone mediated mechanisms of cancer promotion and progression. These projects involve cellular, molecular and biochemical techniques as well as molecular modeling approaches to estrogen, androgen and progestin activity. Dr. Wiese has published papers involving endocrine disruption, structure-activity relationships of hormone active chemicals and estrogen mediated effects on gene induction and proliferation in breast cancer cells.
Select Publications: